Ra Pharmaceuticals, Inc.
(NASDAQ : RARX)

( )
RARX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Co.
-0.27%63.771.4%$1734.36m
JNJJohnson & Johnson
0.07%141.440.7%$888.04m
PFEPfizer Inc.
-0.55%38.330.9%$745.36m
MRKMerck & Co., Inc.
0.32%89.240.7%$681.24m
ABBVAbbVie, Inc.
-1.07%87.782.3%$606.93m
LLYEli Lilly & Co.
-0.14%121.531.1%$363.78m
NVSNovartis AG
0.25%93.290.2%$148.80m
AZNAstraZeneca Plc
0.92%48.361.2%$138.82m
GSKGlaxoSmithKline Plc
0.13%45.990.2%$135.62m
RETAReata Pharmaceuticals, Inc.
2.84%206.753.5%$115.81m
SNYSanofi
0.57%49.790.2%$108.98m
KRTXKaruna Therapeutics, Inc.
-11.24%65.250.0%$103.88m
NVONovo Nordisk A/S
1.33%57.250.1%$91.99m
ALLKAllakos, Inc.
-2.21%123.190.0%$74.48m
FTSVForty Seven, Inc.
-7.72%35.750.0%$49.11m

Company Profile

Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of peptide-based drugs for a variety of therapeutic uses. The company's product include RA101495 SC, which is an injection into the tissue under the skin, for the treatment of paroxysmal nocturnal hemoglobinuria. Ra Pharmaceuticals was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA.